Hemostatic devices and methods of use
AssigneeMedtronic, Inc.
InventorsSatish Pulapura, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco
Life of this patent
Estimating the term…
Abstract
An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.
Claims18
An anchorage device configured to surround an implantable medical device, the anchorage device comprising:
- a substrate comprising a first piece and a second piece that is joined with the first piece, the first piece being made entirely of a hemostatic agent and the second piece comprising an active pharmaceutical ingredient,
- wherein the hemostatic agent is tranexamic acid.
An anchorage device configured to surround an implantable medical device, the anchorage device comprising a non-biodegradable substrate including a first piece and a second piece that is joined with the first piece to form a pocket, inner surfaces of the pieces defining a cavity of the pocket configured for disposal of the implantable medical device, the first piece being formed entirely by a hemostatic agent and the second piece being coated with a polymer, the polymer comprising a tyrosine-derived polyarylate, rifampin and minocycline, wherein the hemostatic agent is tranexamic acid.
An anchorage device comprising:
- a biodegradable substrate including a first piece and a second piece that is joined with the first piece to form a pocket, inner surfaces of the pieces defining a cavity of the pocket, the first piece being formed entirely from a hemostatic agent and the second piece being coated with a polymer, the polymer comprising a tyrosine-derived polyarylate, rifampin and minocycline, wherein the hemostatic agent is tranexamic acid;
- and
- an implantable medical device positioned within the cavity, the implantable medical device being selected from a group consisting of neurostimulators, pacemakers and implantable cardioverter defibrillators.
Dependencies are inferred from the claim text.